Home » Optimer Says Diarrhea Drug Successful in Second Trial
Optimer Says Diarrhea Drug Successful in Second Trial
Optimer Pharmaceuticals Inc said the second late-stage study for Prulifloxacin to treat infectious diarrhea met the main goal and plans to file for regulatory approval by the end of 2009.
CNBC
CNBC
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May